Pharmaceutical Product Development 
To find out more about Pharmaceutical Product Development, please contact:
Robert Feltz, Director of Analytical and Formulation Services
Our formulation development capabilities:
- Immediate, orally disintegrating, modified, delayed, extended release and controlled-release tablets and capsules
- Over-encapsulation for double-blind studies
- Bioavailability enhancement
- Highly-potent compounds
- DEA controlled substances (Schedule I-V)
- Combination of multiple APIs
- Matching placebo (solid, semi-solid and liquid dosage form)
- Powder/blend filling in bottles, vials and pouches using automatic filling machine
- Drug layering and particle coating (Wurster column and top spray coating processes)
- Liquid in hard gel capsule and banding/sealing
- Solution, suspension, powder for reconstitution
- Tablet, capsule and pellet coating
- Semi-solid and topical formulation development
Trust Sharp with your formulation development
Our formulation development services and analytical testing capabilities can prepare your innovations for Phase I in as little as four weeks. We know what it takes to get your product into clinical trials, evaluating critical quality attributes (CQAs) from R&D to GMP manufacturing.
We treat your formulation as our own, working closely with you to overcome challenges and optimize your product for a wide range of dosage forms. Our time-tested approach has flexibility built in, backed up by our robust quality-by-design framework, to maximize efficiency and minimize risk.
With Sharp, you get a partnership shaped around you. We are commited to protecting your innovation and supporting you to the next stop on your journey, clinical trials.
Our analytical and research & development teams use advanced investigative technologies to provide clients with the innovation required to move a product from clinical development to commercialization and ultimately to patients.
